BeStock  
Stocks › Biotechnology › BBIO

BridgeBio Pharma BBIO

US equityMarket cap rank #1114Biotechnology
$76.03 −$2.15 (-2.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $76.03 0.00%
Open$77.85
Prev close$78.18
Day range$75.46 – $78.24
Volume1.48M
Market cap$14.81B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$353.17M+192.6% YoY
Operating profit-$11.64M+91.5% YoY
Net profit-$60.50M+67.3% YoY
Diluted EPS-$0.42+55.8% YoY
Free cash flow-$44.46M+60.5% YoY
Operating cash flow-$44.17M

Revenue, last 8 quarters

$5.9MDec '24$116.6MMar '25$110.6MJun '25$120.7MSep '25$154.2MDec '25$194.5MMar '26$243.7MJun '26$353.2MSep '26

Net profit, last 8 quarters

$-267.4MDec '24$-169.6MMar '25$-183.8MJun '25$-184.9MSep '25$-194.6MDec '25$-166.6MMar '26$-155.9MJun '26$-60.5MSep '26

Diluted EPS by quarter

-1.40Dec '24-0.88Mar '25-0.95Jun '25-0.95Sep '25-1.00Dec '25-0.84Mar '26-0.78Jun '26-0.42Sep '26

Free cash flow by quarter

$-198.6MDec '24$-200.8MMar '25$-85.8MJun '25$-112.4MSep '25$-56.5MDec '25$-197.3MMar '26$-71.5MJun '26$-44.5MSep '26

Annual revenue

$8.2MFY20$69.7MFY21$77.6MFY22$9.3MFY23$221.9MFY24$502.1MFY25

Profitability & balance sheet

Gross margin94.3%
Operating margin-37.3%
Net margin-62.6%
Return on assets-37.5%
Current ratio2.09
Liabilities / assets176.5%
Cash & investments$1.54B
Total debt$2.49B
Net cash (debt)-$953.20M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $353.17M $243.68M $194.52M $502.08M $154.18M
Total Operating Revenue $353.17M $243.68M $194.52M $502.08M $154.18M
Cost of Revenue $20.45M $15.05M $9.94M $20.96M $8.11M
Gross Profit $332.72M $228.63M $184.58M $481.11M $146.07M
Operating Expense $344.36M $335.71M $290.53M $983.18M $274.50M
Selling and Admin Expenses $200.85M $186.26M $163.90M $531.23M $158.09M
Research & Development $143.51M $149.45M $126.64M $451.95M $116.42M
Operating Profit -$11.64M -$107.08M -$105.96M -$502.06M -$128.43M
Net Non-Operating Interest Income (Expense) -$42.43M -$47.96M -$46.57M -$158.39M -$45.98M
Non-Operating Interest Income $13.11M $6.66M $6.25M $19.85M $4.33M
Non-Operating Interest Expense $55.54M $54.62M $52.82M $178.24M $50.31M
Other Income (Expense) -$5.20M -$848,000.00 -$14.03M -$72.05M -$20.34M
Earnings from Equity Interest -$7.31M -$6.44M -$18.28M -$72.61M -$21.03M
Special Income (Charges) $2.12M $5.59M $0.00 -$42.50M -$42.37M
-Less:Restructuring and Mergern & Acquisition $0.00 $0.00 $0.00 $21.35M $11.13M
-Gain on Sale of Property/Plant/Equipment $2.12M $5.59M – – –
Pretax Profit -$59.27M -$155.89M -$166.56M -$732.50M -$194.76M
Tax $1.23M $0.00 – $435,000.00 -$120,000.00
Net Profit -$60.50M -$155.89M -$166.56M -$732.94M -$194.64M
Profit from Continuing Operations -$60.50M -$155.89M -$166.56M -$732.94M -$194.64M
Minority Interests -$3.79M -$3.68M -$2.51M -$8.01M -$1.77M
Net Income to Parent Company -$56.71M -$152.22M -$164.04M -$724.93M -$192.86M
Preferred Stock Dividends $26.29M – – – –
Net Income to Common Stockholders -$83.00M -$152.22M -$164.04M -$724.93M -$192.86M
Basic EPS -$0.42 -$0.78 -$0.84 -$3.78 -$1.00
Diluted EPS -$0.42 -$0.78 -$0.84 -$3.78 -$1.00
Other Non-Operating Income (Expenses) – – $4.25M $43.06M –
-Less:Impairment of Capital Assets – – – $0.00 $0.00
-Less:Other Special Charges – – – $21.16M $0.00
-Gain on Sale Of Business – – – $0.00 $0.00

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.16B $1.22B $1.37B $936.03M $936.03M
Total Current Assets $2.04B $1.09B $1.24B $797.75M $797.75M
Cash and Cash Equivalents & Short-Term Investments $1.54B $720.16M $940.19M $587.48M $587.48M
-Cash and Cash Equivalents $1.53B $677.91M $879.89M $570.12M $570.12M
-Short Term Investments $5.49M $42.25M $60.30M $17.36M $17.36M
Receivables $375.09M $254.48M $205.23M $139.44M $139.44M
-Accounts Receivable $375.09M $254.48M $205.23M $139.44M $139.44M
Inventory $59.72M $52.84M $32.98M $26.75M $26.75M
Other Current Assets $70.94M $65.65M $62.91M $44.07M $44.07M
Total Non-Current Assets $117.18M $124.16M $129.68M $138.28M $138.28M
Net PPE $20.79M $22.31M $22.17M $13.52M $13.52M
-Gross PPE $20.79M $22.31M $22.17M $13.52M $13.52M
Investments and Advances $47.78M $55.10M $61.53M $79.97M $79.97M
-Long Term Equity Investment $47.78M $55.10M $61.53M $79.97M $79.97M
Goodwill and Other Intangible Assets $25.92M $26.64M $27.36M $28.08M $28.08M
Other Non-Current Assets $22.69M $20.12M $18.62M $16.71M $16.71M
Total Liabilities $3.82B $3.72B $3.64B $3.01B $3.01B
Total Current Liabilities $977.24M $890.65M $816.37M $287.97M $287.97M
Payables $101.94M $27.20M $29.06M $36.23M $36.23M
-Accounts Payable $88.26M $27.20M $29.06M $36.23M $36.23M
-Dividends Payable $13.68M – – – –
Current Accrued Expenses $217.36M $227.37M $168.45M $150.44M $150.44M
Short-Term Debt and Capital Lease Obligation $550.42M $551.27M $551.92M $6.19M $6.19M
-Current Debt $548.43M $547.96M $547.48M – –
-Current Capital Lease Obligation $1.99M $3.32M $4.44M $6.19M $6.19M
Current Deferred Liabilities $40.84M $34.83M $27.60M $18.41M $18.41M
Total Non-Current Liabilities $2.84B $2.83B $2.82B $2.72B $2.72B
Long Term Debt and Capital Lease Obligation $1.94B $1.94B $1.94B $1.86B $1.86B
-Long Term Debt $1.93B $1.93B $1.93B $1.85B $1.85B
-Long Term Capital Lease Obligation $14.65M $14.97M $14.22M $3.81M $3.81M
Non-Current Deferred Liabilities $893.02M $889.80M $882.96M $868.11M $868.11M
Other Non-Current Liabilities $1.41M $240,000.00 $229,000.00 $244,000.00 $244,000.00
Total Equity -$1.65B -$2.51B -$2.27B -$2.08B -$2.08B
Stockholders' Equity -$1.66B -$2.52B -$2.28B -$2.09B -$2.09B
Capital Stock $942.69M $206,000.00 $204,000.00 $202,000.00 $202,000.00
-Common Stock $207,000.00 $206,000.00 $204,000.00 $202,000.00 $202,000.00
-Preferred Stock $942.48M $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $2.17B $2.16B $2.11B $2.06B $2.06B
Retained Earnings -$4.19B -$4.14B -$3.99B -$3.82B -$3.82B
Less: Treasury Stock -$580.78M -$533.28M -$405.78M -$323.28M -$323.28M
Gains/Losses Not Affecting Retained Earnings -$95,000.00 -$7,000.00 -$8,000.00 $12,000.00 $12,000.00
Minority Interests $8.84M $9.32M $9.49M $10.03M $10.03M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$44.17M -$71.10M -$197.28M -$445.91M -$56.42M
Net cash flow from continuing operations -$44.17M -$71.10M -$197.28M -$445.91M -$56.42M
Net Income from Continuing Operations -$60.50M -$155.89M -$166.56M -$732.94M -$194.64M
Gain/Loss from Continuing Operations $214,000.00 $6.44M $18.28M $84.93M $31.03M
Depreciation & Depletion & Amortization $1.07M $1.05M $1.19M $5.43M $1.44M
Other Non-Cash Items $48.06M $44.90M $43.16M $136.01M $42.81M
Change in Working Capital -$77.10M -$9.29M -$124.74M -$51.06M $49.61M
-Change in Receivables -$120.61M -$49.26M -$65.78M -$134.72M -$22.93M
-Change in Inventory -$7.48M -$21.11M -$7.05M -$25.31M -$1.95M
-Change in Prepaid Assets -$6.65M -$1.38M -$18.85M -$8.78M $8.75M
-Change in Payables and Accrued Expense $68.28M $19.90M -$31.65M $56.79M $44.15M
-Change in Other Current Assets -$2.57M -$1.49M -$1.80M $1.11M $545,000.00
-Change in Other Current Liabilities -$5.83M $45.97M $2.77M -$6.55M -$54.82M
-Change In Other Working Capital -$2.26M -$1.92M -$2.38M $66.38M $75.86M
Net cash flow from investing $36.61M $17.89M -$42.74M -$24.49M -$14.35M
Net Cash Flow from Continuing Investing Activities $36.61M $17.89M -$42.74M -$24.49M -$14.35M
Net PPE Purchase and Sale -$290,000.00 -$443,000.00 -$69,000.00 -$1.10M -$33,000.00
Net Intangibles Purchase and Sale $0.00 $0.00 $0.00 -$8.50M $0.00
Net Investment Purchase and Sale $36.90M $18.33M -$42.67M -$17.20M -$14.32M
Financing Cash Flow $863.01M -$148.77M $549.89M $359.29M -$2.18M
Net Cash Flow from Continuing Financing Activities $863.01M -$148.77M $549.89M $359.29M -$2.18M
Net Issuance Payments Of Debt $0.00 $0.00 $632.50M $116.00M $0.00
Net Common Stock Issuance -$47.59M -$131.77M -$86.57M -$62.50M -$7.43M
Proceeds from Stock Option Exercised $10.16M $5.22M $28.06M $34.15M $13.21M
Net Other Financing Charges -$30.77M -$22.22M -$24.09M $271.65M -$7.96M
Ending Cash Balance $1.54B $680.04M $882.02M $572.14M $572.14M
Net Change in Cash $855.45M -$201.98M $309.88M -$111.10M -$72.96M
Beginning Cash Balance $680.04M $882.02M $572.14M $683.24M $645.10M
Free Cash Flow -$44.46M -$71.54M -$197.35M -$455.50M -$56.45M
Net Business Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on BBIO.

Sign in to join the discussion.

Scroll to Top